Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOFScan vs TOF-Watch SX for Neuromuscular Monitoring
NCT02880787Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Randomised, open-label trial, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Time of recovery of the first response of train of four monitoring at day 0. Status: unknown.
Beyond the preview
Go deeper on NCT02880787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880787.